Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment. [electronic resource]
Producer: 20180919Description: 14 p. digitalISSN:- 1472-6823
- Adamantane -- analogs & derivatives
- Adult
- Age of Onset
- Biomarkers -- analysis
- Blood Glucose -- analysis
- Diabetes Mellitus, Type 2 -- diagnosis
- Dipeptides -- therapeutic use
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Glycated Hemoglobin -- analysis
- Glycemic Index
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin-Secreting Cells -- drug effects
- Metformin -- therapeutic use
- Polycystic Ovary Syndrome -- drug therapy
- Prognosis
- Prospective Studies
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.